Cargando…
Opposing inflammatory biomarker responses to sleep disruption in cancer patients before and during oncological therapy
BACKGROUND: Sleep disruption is known to be highly prevalent in cancer patients, aggravated during oncological treatment and closely associated with reduced quality of life, therapeutic outcome and survival. Inflammatory factors are associated with sleep disruption in healthy individuals and cancer...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534604/ https://www.ncbi.nlm.nih.gov/pubmed/36213755 http://dx.doi.org/10.3389/fnins.2022.945784 |